Patents Assigned to Threshold Pharmaceuticals, Inc.
  • Treatment of cancer with 2-deoxyglucose
    Patent number: 6979675
    Abstract: The compound 2-deoxyglucose can be used to treat cancer and to improve patient outcome when administered at a therapeutically effective dose, and, optionally, co-administered with other anti-cancer drugs, or in combination with surgical resection or radiation therapy.
    Type: Grant
    Filed: January 9, 2004
    Date of Patent: December 27, 2005
    Assignee: Threshold Pharmaceuticals, Inc.
    Inventor: George Tidmarsh
  • Prevention and treatment of benign prostatic hyperplasia
    Publication number: 20050272795
    Abstract: A method for treatment or prophylaxis of benign prostatic hyperplasia by administration of lonidamine or a lonidamine analog is provided. Also provided are unit dosage forms of lonidamine or an analog, useful for such treatment and prophylaxis.
    Type: Application
    Filed: June 29, 2005
    Publication date: December 8, 2005
    Applicant: Threshold Pharmaceuticals, Inc.
    Inventor: George Tidmarsh
  • Dosage forms for treatment of benign prostatic hyperplasia
    Publication number: 20050271723
    Abstract: A method for treatment or prophylaxis of benign prostatic hyperplasia by administration of lonidarrine or a lonidamine analog is provided. Also provided are unit dosage forms of lonidamine or an analog, useful for such treatment and prophylaxis.
    Type: Application
    Filed: June 29, 2005
    Publication date: December 8, 2005
    Applicant: Threshold Pharmaceuticals, Inc.
    Inventor: George Tidmarsh
  • Prevention and treatment of benign prostatic hyperplasia using lonidamine and lonidamine analogs
    Publication number: 20050272796
    Abstract: A method for treatment or prophylaxis of benign prostatic hyperplasia by administration of lonidamine or a lonidamine analog is provided. Also provided are unit dosage forms of lonidamine or an analog, useful for such treatment and prophylaxis.
    Type: Application
    Filed: June 29, 2005
    Publication date: December 8, 2005
    Applicant: Threshold Pharmaceuticals, Inc.
    Inventor: George Tidmarsh
  • Treatment of cancer with 2-deoxyglucose
    Publication number: 20050245462
    Abstract: The compound 2-deoxyglucose can be used to treat cancer and to improve patient outcome when administered at a therapeutically effective dose, and, optionally, co-administered with other anti-cancer drugs, or in combination with surgical resection or radiation therapy.
    Type: Application
    Filed: June 30, 2005
    Publication date: November 3, 2005
    Applicant: Threshold Pharmaceuticals, Inc.
    Inventor: George Tidmarsh
  • Compositions and methods for treating cancer
    Publication number: 20040029815
    Abstract: Methods and compositions are provided for the treatment of cancer that take advantage of the increased uptake of glucose-anti-neoplastic agent conjugates in cancer cells relative to normal cells.
    Type: Application
    Filed: March 28, 2003
    Publication date: February 12, 2004
    Applicant: Threshold Pharmaceuticals, Inc.
    Inventors: George Tidmarsh, Mark Matteucci, Photon Rao
  • Methods for cancer imaging
    Publication number: 20030152518
    Abstract: Methods are provided for cancer and pre-cancer detection by increased uptake of fluorophore glucose or deoxyglucose conjugates in cancerous and pre-cancerous cells relative to normal cells.
    Type: Application
    Filed: December 20, 2002
    Publication date: August 14, 2003
    Applicant: Threshold Pharmaceuticals, Inc.
    Inventors: George Tidmarsh, Mark Matteucci